ABVC BioPharma, Inc. (ABVC)
0.8701
-0.04
(-4.43%)
USD |
NASDAQ |
Nov 19, 15:56
ABVC BioPharma Total Assets (Quarterly) : 20.30M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 20.30M |
| June 30, 2026 | 19.40M |
| March 31, 2026 | 19.73M |
| December 31, 2025 | 21.06M |
| September 30, 2025 | 21.21M |
| June 30, 2025 | 16.24M |
| March 31, 2025 | 14.88M |
| December 31, 2024 | 7.540M |
| September 30, 2024 | 14.46M |
| June 30, 2024 | 14.63M |
| March 31, 2024 | 14.69M |
| December 31, 2023 | 7.784M |
| September 30, 2023 | 17.27M |
| June 30, 2023 | 10.22M |
| March 31, 2023 | 11.86M |
| December 31, 2022 | 10.93M |
| September 30, 2022 | 12.06M |
| June 30, 2022 | 15.59M |
| March 31, 2022 | 14.10M |
| December 31, 2021 | |
| September 30, 2021 | 14.84M |
| June 30, 2021 | 11.65M |
| March 31, 2021 | 13.46M |
| December 31, 2020 | 14.77M |
| September 30, 2020 | 9.916M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.04M |
| March 31, 2020 | 10.50M |
| December 31, 2019 | 10.99M |
| September 30, 2019 | 11.69M |
| June 30, 2019 | 7.140M |
| March 31, 2019 | 7.450M |
| December 31, 2018 | 5.940M |
| September 30, 2018 | 2.594M |
| June 30, 2018 | 2.650M |
| March 31, 2018 | 2.556M |
| December 31, 2017 | 2.643M |
| September 30, 2017 | 2.755M |
| June 30, 2017 | 0.0081M |
| December 31, 2016 | 0.0186M |
| September 30, 2016 | 0.1774M |
| June 30, 2016 | 0.0887M |
| March 31, 2016 | 0.8765M |
| December 31, 2015 | 0.0649M |
| September 30, 2015 | 0.0682M |
| June 30, 2015 | 0.0673M |
| March 31, 2015 | 0.0673M |
| December 31, 2014 | 0.0646M |
| September 30, 2014 | 0.0646M |
| June 30, 2014 | 0.2319M |
| March 31, 2014 | 0.2319M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| T2 Biosystems, Inc. | -- |
| Anika Therapeutics, Inc. | 189.60M |
| Perspective Therapeutics, Inc. | 365.68M |
| MiMedx Group, Inc. | 264.55M |
| Abbott Laboratories | 108.25B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.554M |
| Shareholders Equity (Quarterly) | 13.05M |
| Debt to Equity Ratio | 0.3057 |
| Current Ratio | 0.1953 |
| Net Debt Paydown Yield | -1.18% |